HPK1-IN-59
HPK1-IN-59 (compound 39) is an orally active HPK1 inhibitor with an IC50 of 0.70 nM. HPK1-IN-59 has favorable oral bioavailability in mice[1].
Product Specifications
UNSPSC
12352005
Target
MAP4K
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
CC(C)(C1=CC(C2=CN(N=C2)CC(C)(O)C)=CC3=CN=C(N=C31)NC4=CC(C(C)(O5)C)=C(C=C4)C5=O)O
Molecular Formula
C28H31N5O4
Molecular Weight
501.58
References & Citations
[1]Wan B, et al. Structure-Guided Optimization of 2-Aminoquinazoline Hematopoietic Progenitor Kinase 1 Inhibitors for Improved Oral Bioavailability and Synergistic Antitumor Immunity. J Med Chem. 2025 May 22;68 (10) :10439-10460.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GAHu/J/PO 1 mL
Goat anti Human J chain of dimeric IgA, conjugated with Horseradish peroxidase
Ask
View Details 
MBS6179829-01 0.1 mL
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (HRP)
Ask
View Details MBS6179829-02 5x 0.1 mL
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (HRP)
Ask
View Details 
